[1]
Yenny, Y. 2019. Aspirin for primary prevention of cardiovaascular events: what are the evidances?. Universa Medicina. 38, 3 (Aug. 2019), 145–146. DOI:https://doi.org/10.18051/UnivMed.2019.v38.145-146.